Frontiers in Cardiovascular Medicine (Nov 2020)

Potential Role and Prognostic Value of Erythropoietin Levels in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

  • Silvia Mas-Peiro,
  • Silvia Mas-Peiro,
  • Silvia Mas-Peiro,
  • Philipp C. Seppelt,
  • Philipp C. Seppelt,
  • Roberta De Rosa,
  • Marie-Isabel Murray,
  • Marie-Isabel Murray,
  • Jörg Yogarajah,
  • Alexander Berkowitsch,
  • Stephan Fichtlscherer,
  • Stephan Fichtlscherer,
  • Stephan Fichtlscherer,
  • Andreas M. Zeiher,
  • Andreas M. Zeiher,
  • Andreas M. Zeiher,
  • Mariuca Vasa-Nicotera,
  • Mariuca Vasa-Nicotera,
  • Mariuca Vasa-Nicotera

DOI
https://doi.org/10.3389/fcvm.2020.605257
Journal volume & issue
Vol. 7

Abstract

Read online

Background: Both EPO levels and anemia have shown prognostic value in several cardiac disorders. An observational study with a prospective follow-up was performed to investigate their independent prognostic roles in severe aortic stenosis.Methods: An up to 36-month follow-up of consecutive patients with severe aortic stenosis undergoing TAVR in a high-volume center was performed. Patients with eGRF <30 mL/min/1.73 m2 were excluded. EPO levels and/or anemia status and its association with mid-term mortality were assessed.Results: Out of 407, 360 met eligibility criteria. Median age was 83 years, with 71.4% having a NYHA class III/IV. Anemia was present in 51.9%, and iron deficiency in 52.8%. Median (IQR) EPO levels were 14.4 (9.30–24.30) mIU/mL. Median follow-up was 566 days. Anemia was associated with overall mortality (HR 2.40, 95% CI 1.51–3.80, p < 0.001). Higher logEPO levels were associated with mid-term mortality (HR 4.05, 95% CI 2.29–7.16, p < 0.001), even after adjusting for clinically and/or statistically relevant factors (multivariate HR 2.25, 95 CI 1.09–4.66, p = 0.029). Kaplan-Meier analyses showed early diverging curves for anemia vs. non-anemia, whereas curves for patients in various EPO level quartiles started to diverge at about 100 days, with differences consistently increasing during the subsequent entire follow-up period.Conclusions: Differently from anemia, which was a strong predictor for both early and late mortality in severe aortic stenosis after TAVR, independent prognostic value of EPO only emerged after post-TAVR recovery. EPO prognostic value was independent from anemia and mild-to-moderate renal dysfunction. High EPO levels could be useful to identify patients with severe aortic stenosis showing a compromised mid-term survival in spite of TAVR use and independently from early TAVR results.

Keywords